A carregar...

Estrogen Down-regulator Fulvestrant Potentiates Antitumor Activity of Fluoropyrimidine in Estrogen-responsive MCF-7 Human Breast Cancer Cells

Background: Endocrine therapy is clinically administered in hormone-responsive breast cancer. Combinations of fluoropyrimidine S-1 and an aromatase inhibitor or anti-estrogen are considered beneficial in Japan. Herein we assessed new combinations of S-1 and fulvestrant. Patients and Methods: Cytotox...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:In Vivo
Main Authors: NUKATSUKA, MAMORU, SAITO, HITOSHI, NOGUCHI, SHINZABURO, TAKECHI, TEIJI
Formato: Artigo
Idioma:Inglês
Publicado em: International Institute of Anticancer Research 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6754987/
https://ncbi.nlm.nih.gov/pubmed/31471390
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11622
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!